Understanding the Future of CDP & Its Role in Society
9:00 am Coffee & Networking
9:50 am Chairs Opening Remarks
10:00 am How to Progress Access to Medical Cannabis in the UK
Sourcing, Extraction and Formulation of Cannabinoids
10:30 am Toward the Establishment of GMP Process: From Cannabis Extraction Methods to Nanotechnology-Based Formulations
11:00 am Networking Break
11:30 am Opportunities & Challenges in Clinical Trials with Focus on Multiple Sclerosis
Linking Cannabinoids to their Therapeutic Potential while Collecting Data on Patient Effects/Outcomes in Both Clinical & Non-Clinical Settings
12:00 pm A Party of Three: The Intriguing Interplay Between Three Cannabinoids for the Treatment of Insomnia
12:30 pm Lunch & Networking Break
1:00 pm The Swiss Army Knife of Cannabis and Cannabinoid Drug Development
1:30 pm Discovery & Development of a Cannabinoid-Derived Therapeutic for Glioblastoma
2:00 pm The Future of Inhaled Cannabinoid-Based Medicine in Cancer: An Alternative Treatment to Improve Quality of Life and Pain Management in Advanced Cancer Patients?
2:30 pm Break
3:30 pm Is the Future of Cannabinoid Pharmaceuticals and Nutraceuticals based on Phytocannabinoids, Synthetics or Augmented Multiple Compound Formulations?
Synopsis
• Single-compound, augmented multiple compound or whole plant fullspectrum?
• Natural vs. synthetic
• How natural source Cannabinoids work to effectively treat:
• Pain and inflammation
• Muscle spasms and seizures
• Nausea and vomiting
Improving Target Identification & Advancing Drug Administration Technology for Improved Efficacy
4:00 pm Real-World Data on Medical Cannabis from Canada’s Clinical Leaders: Santé Cannabis
4:30 pm Drug Target Prediction and Development Using an Integrated Computational & High-Throughput Screening Approach
5:00 pm Cannabinoid-Related IP: Novelty in the Treasure Trove
Synopsis
- Teaching plants to do new tricks
- Navigating jurisdictional differences
- Methods of use, methods of production, compositions and formulations